Insufficient scRNA-seq data for expression of FZD10 at single-cell level.
Insufficient scRNA-seq data for expression of FZD10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 491.16 | 233 / 245 | 55% | 3.33 | 275 / 502 |
ovary | 53% | 416.94 | 95 / 180 | 83% | 21.93 | 357 / 430 |
uterus | 58% | 150.12 | 99 / 170 | 67% | 21.00 | 307 / 459 |
esophagus | 57% | 833.30 | 824 / 1445 | 68% | 30.32 | 124 / 183 |
lung | 64% | 112.86 | 368 / 578 | 42% | 13.60 | 488 / 1155 |
bladder | 67% | 232.38 | 14 / 21 | 37% | 8.55 | 187 / 504 |
thymus | 84% | 177.37 | 550 / 653 | 3% | 0.21 | 21 / 605 |
tonsil | 0% | 0 | 0 / 0 | 87% | 22.14 | 39 / 45 |
breast | 64% | 134.71 | 292 / 459 | 23% | 2.01 | 256 / 1118 |
skin | 72% | 907.38 | 1306 / 1809 | 4% | 0.53 | 21 / 472 |
adipose | 47% | 93.54 | 563 / 1204 | 0% | 0 | 0 / 0 |
brain | 41% | 53.84 | 1095 / 2642 | 3% | 0.41 | 19 / 705 |
intestine | 22% | 27.98 | 210 / 966 | 22% | 7.68 | 118 / 527 |
stomach | 18% | 25.90 | 63 / 359 | 19% | 4.82 | 53 / 286 |
muscle | 30% | 68.03 | 241 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 22% | 35.25 | 293 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 2% | 1.71 | 5 / 328 | 17% | 1.33 | 30 / 178 |
adrenal gland | 4% | 3.81 | 10 / 258 | 11% | 1.22 | 25 / 230 |
kidney | 4% | 9.38 | 4 / 89 | 5% | 0.54 | 43 / 901 |
liver | 0% | 0 | 0 / 226 | 2% | 0.16 | 9 / 406 |
heart | 2% | 2.11 | 17 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0030182 | Biological process | neuron differentiation |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0035567 | Biological process | non-canonical Wnt signaling pathway |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0009986 | Cellular component | cell surface |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FZD10 |
Protein name | Frizzled homolog 10 (Drosophila) Frizzled-10 (Fz-10) (hFz10) (FzE7) (CD antigen CD350) Frizzled class receptor 10 |
Synonyms | |
Description | FUNCTION: Receptor for Wnt proteins. Functions in the canonical Wnt/beta-catenin signaling pathway (By similarity). The canonical Wnt/beta-catenin signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues (Probable). . |
Accessions | Q9ULW2 F5H450 ENST00000229030.5 ENST00000539839.1 Q6NSL8 |